Related Experiment Video

Updated: May 30, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas

Yingyi Wang1, Xiefeng Wang, Junxia Zhang

  • 1Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, 300, Guangzhou Road, 210029 Nanjing, People's Republic of China.

Journal of Neuro-Oncology
|August 16, 2011
PubMed

Insights

MicroRNAs (miRNAs) are crucial in glioma development by regulating the EGFR/PTEN/AKT pathway. Understanding these interactions offers new avenues for glioma diagnosis and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gliomas represent the most frequent malignant primary brain tumors.
  • Current treatments like surgery, radiation, and chemotherapy offer limited improvement in patient prognosis.
  • MicroRNAs (miRNAs) are key regulators in cellular processes and implicated in glioma pathogenesis.

Purpose of the Study:

  • To review recent findings on the role of miRNAs in regulating the EGFR/PTEN/AKT pathway in gliomas.
  • To highlight the significance of miRNA-mediated regulation of this pathway for glioma progression.
  • To explore novel diagnostic and therapeutic strategies targeting miRNAs and the EGFR/PTEN/AKT pathway.

Main Methods:

  • Literature review of recent studies on miRNAs, gliomas, and the EGFR/PTEN/AKT pathway.
  • Analysis of miRNA involvement in gene expression regulation.
  • Focus on the interplay between miRNAs and the EGFR/PTEN/AKT signaling cascade.

Main Results:

  • miRNAs play a critical role in the development and progression of gliomas.
  • The EGFR/PTEN/AKT pathway is significantly influenced by miRNA-mediated regulation.
  • Dysregulation of specific miRNAs impacts glioma tumorigenesis.

Conclusions:

  • miRNAs are pivotal in glioma progression through modulation of the EGFR/PTEN/AKT pathway.
  • Targeting miRNAs offers a promising strategy for novel glioma therapies.
  • Further research into miRNA-EGFR/PTEN/AKT interactions is essential for advancing glioma diagnosis and treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...